Provided By GlobeNewswire
Last update: May 7, 2025
-- First Quarter 2025 Performance Reflects Contribution from Multiple Revenue Streams Across Geographies, Efforts to Support Strong Balance Sheet and Continued Strategic Execution to Maximize Global Value of VASCEPA®/VAZKEPA® --
Read more at globenewswire.comNASDAQ:AMRN (6/13/2025, 8:00:01 PM)
13.25
-0.13 (-0.97%)
Find more stocks in the Stock Screener